Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Qiagen's Clinical Interpretation Tools; Station X's GenePool Reference; More


Qiagen has announced the impending launches of clinical interpretation tools CLC Cancer Research Workbench and Ingenuity Clinical. CLC Cancer Research Workbench will launch in April 2014 and is a cancer-specific analysis workflow that interprets next-gen sequencing data. Ingenuity Clinical is being used by 20 clinical testing laboratories in early access and will launch commercially later this year. The solution does automated scoring, interpretation, and reporting of findings in standardized, HIPPA-compliant formats.

Station X has launched GenePool Reference, software for the management, sharing, and analysis of population-scale genomic data. The firm has made available all of the gene expression data from the Cancer Genome Atlas, which includes RNA-seq data covering 25 cancer types. In total, GenePool Reference currently contains over 7,000 samples of DNA and RNA sequence data.

Connective Tissue Gene Tests has added deletion and duplication testing to 12 of its Sanger sequencing tests to diagnose genetic forms of connective tissue disorders. The company offers a total of 33 Sanger-based tests and nine next-gen sequencing-based gene panels.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.